⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7648923 | 0.71 | — | — | |
| SCHEMBL45002 | 0.67 | — | — | |
| Hydrogen Sulfide SCHEMBL7933936 | 0.62 | — | — | |
| SCHEMBL166599 | 0.61 | — | — | |
| SCHEMBL31268158 | 0.61 | — | — | |
| Hydrochloric Acid SCHEMBL28526767 | 0.61 | — | — | |
| Hydrochloric Acid SCHEMBL9863746 | 0.55 | — | — | |
| SCHEMBL29283229 | 0.55 | — | — | |
| SCHEMBL28824575 | 0.55 | — | — | |
| SCHEMBL10354529 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140155429-A1 | Treatment of Cognitive Disorders with Certain Alpha-7 Nicotinic Acid Receptor Agonists in Combination with Nicotine | ENVIVO PHARMACEUTICALS, INC. (US) | 2014-06-05 | — | — | US | claimed |
| EP-2725906-A1 | METHODS OF TREATMENT OF LIMITED COGNITIVE IMPAIRMENT | Envivo Pharmaceuticals, Inc. (US) | 2014-05-07 | — | — | EP | claimed |
| EP-2706854-A1 | TREATMENT OF COGNITIVE DISORDERS WITH CERTAIN ALPHA-7 NICOTINIC ACID RECEPTOR AGONISTS IN COMBINATION WITH NICOTINE | Envivo Pharmaceuticals, Inc. (US) | 2014-03-19 | — | — | EP | claimed |
| WO-2013006365-A1 | METHODS OF TREATMENT OF LIMITED COGNITIVE IMPAIRMENT | ENVIVO PHARMACEUTICALS, INC. (US) | 2013-01-10 | — | — | WO | claimed |
| WO-2012154710-A1 | TREATMENT OF COGNITIVE DISORDERS WITH CERTAIN ALPHA-7 NICOTINIC ACID RECEPTOR AGONISTS IN COMBINATION WITH NICOTINE | ENVIVO PHARMACEUTICALS, INC. (US) | 2012-11-15 | — | — | WO | claimed |
| EP-0854861-A1 | OXYAMINO OXIME ETHERS, METHODS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, AND AGENTS CONTAINING THEM AND USED FOR CONTROLLING HARMFUL FUNGI AND PESTS | BASF AKTIENGESELLSCHAFT (DE) | 1998-07-29 | — | — | EP | claimed |
| WO-1997013747-A1 | OXYAMINO OXIME ETHERS, METHODS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, AND AGENTS CONTAINING THEM AND USED FOR CONTROLLING HARMFUL FUNGI AND PESTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-04-17 | — | — | WO | claimed |
| US-20260132404-A1 | MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| US-20250304613-A1 | AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE CONJUGATION APPROACH | ALNYLAM PHARMACEUTICALS, INC. (US) | 2025-10-02 | — | — | US | disclosed |
| EP-4561631-A2 | MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS | Alnylam Pharmaceuticals, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| EP-4367125-A1 | AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE BIOCONJUGATION APPROACH | Alnylam Pharmaceuticals, Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2024073709-A2 | MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2023283434-A9 | AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE BIOCONJUGATION APPROACH | ALNYLAM PHARMACEUTICALS, INC. (US) | 2024-03-28 | — | — | WO | disclosed |
| US-20060046983-A1 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY | 2006-03-02 | — | — | US | disclosed |
| WO-2006020082-A1 | INHIBITORS OF HCV REPLICATION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-02-23 | — | — | WO | disclosed |
| US-20050215577-A1 | Tetrahydrocarbazoles and derivatives | HOFFMANN-LA ROCHE INC. | 2005-09-29 | — | — | US | disclosed |
| US-20040137334-A1 | Volume hologram recording photosensitive composition, volume hologram recording photosensitive medium and volume hologram | DAI NIPPON PRINTING CO., LTD. (JP) | 2004-07-15 | — | — | US | disclosed |
| US-20030129385-A1 | Photocurable resin composition, finely embossed pattern-forming sheet, finely embossed pattern transfer sheet, optical article, stamper and method of forming finely embossed pattern | DAI NIPPON PRINTING CO., LTD. (JP) | 2003-07-10 | — | — | US | disclosed |
| US-6316482-B1 | FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-11-13 | — | — | US | disclosed |
| US-6207693-B1 | Benzamide derivatives having a vasopressin antagonistic activity | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-03-27 | — | — | US | disclosed |